BioHarvest Sciences Statistics
Total Valuation
BHST has a market cap or net worth of $161.61 million. The enterprise value is $178.97 million.
Important Dates
The last earnings date was Monday, August 11, 2025, before market open.
| Earnings Date | Aug 11, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
BHST has 17.33 million shares outstanding. The number of shares has increased by 20.58% in one year.
| Current Share Class | 17.33M |
| Shares Outstanding | 17.33M |
| Shares Change (YoY) | +20.58% |
| Shares Change (QoQ) | +0.00% |
| Owned by Insiders (%) | 19.28% |
| Owned by Institutions (%) | 0.62% |
| Float | 12.49M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 5.35 |
| Forward PS | 4.64 |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 5.93 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.60
| Current Ratio | 0.60 |
| Quick Ratio | 0.36 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -149.45 |
Financial Efficiency
Return on equity (ROE) is -973.22% and return on invested capital (ROIC) is -26.96%.
| Return on Equity (ROE) | -973.22% |
| Return on Assets (ROA) | -16.70% |
| Return on Invested Capital (ROIC) | -26.96% |
| Return on Capital Employed (ROCE) | -68.48% |
| Revenue Per Employee | $15.10M |
| Profits Per Employee | -$6.03M |
| Employee Count | 2 |
| Asset Turnover | 1.10 |
| Inventory Turnover | 3.79 |
Taxes
In the past 12 months, BHST has paid $85,000 in taxes.
| Income Tax | 85,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +65.60% in the last 52 weeks. The beta is 1.33, so BHST's price volatility has been higher than the market average.
| Beta (5Y) | 1.33 |
| 52-Week Price Change | +65.60% |
| 50-Day Moving Average | 7.41 |
| 200-Day Moving Average | 6.29 |
| Relative Strength Index (RSI) | 74.22 |
| Average Volume (20 Days) | 19,022 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, BHST had revenue of $30.19 million and -$12.06 million in losses. Loss per share was -$0.70.
| Revenue | 30.19M |
| Gross Profit | 17.52M |
| Operating Income | -7.32M |
| Pretax Income | n/a |
| Net Income | -12.06M |
| EBITDA | -6.63M |
| EBIT | -7.32M |
| Loss Per Share | -$0.70 |
Full Income StatementBalance Sheet
The company has $3.73 million in cash and $21.09 million in debt, giving a net cash position of -$17.37 million or -$1.00 per share.
| Cash & Cash Equivalents | 3.73M |
| Total Debt | 21.09M |
| Net Cash | -17.37M |
| Net Cash Per Share | -$1.00 |
| Equity (Book Value) | -4.22M |
| Book Value Per Share | -0.24 |
| Working Capital | -6.78M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$7.03 million and capital expenditures -$2.18 million, giving a free cash flow of -$9.21 million.
| Operating Cash Flow | -7.03M |
| Capital Expenditures | -2.18M |
| Free Cash Flow | -9.21M |
| FCF Per Share | -$0.53 |
Full Cash Flow StatementMargins
Gross margin is 58.02%, with operating and profit margins of -24.25% and -39.95%.
| Gross Margin | 58.02% |
| Operating Margin | -24.25% |
| Pretax Margin | -39.67% |
| Profit Margin | -39.95% |
| EBITDA Margin | -21.94% |
| EBIT Margin | -24.25% |
| FCF Margin | n/a |
Dividends & Yields
BHST does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -20.58% |
| Shareholder Yield | -20.58% |
| Earnings Yield | -7.46% |
| FCF Yield | -5.70% |
Analyst Forecast
The average price target for BHST is $13.00, which is 39.43% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $13.00 |
| Price Target Difference | 39.43% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 2 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on June 3, 2024. It was a reverse split with a ratio of 1:35.
| Last Split Date | Jun 3, 2024 |
| Split Type | Reverse |
| Split Ratio | 1:35 |
Scores
BHST has an Altman Z-Score of -3.34 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -3.34 |
| Piotroski F-Score | 3 |
